Speaker

Kenneth Crook

Head of Translational Medicine, Engimmune Therapeutics

Kenneth Crook, Head of Translational Medicine at Engimmune Therapeutics, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Panel Discussion: Competing Beyond Dupixent: Leveraging Unique Mechanisms of Action & Long-Acting Drugs to Differentiate in the Next Wave of Atopic Dermatitis Therapeutics”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- PanelPanel Discussion: Competing Beyond Dupixent: Leveraging Unique Mechanisms of Action & Long-Acting Drugs to Differentiate in the Next Wave of Atopic Dermatitis TherapeuticsWith Vanessa Morales-Tirado, Akanksha Mittal
- SpeakerTargeting Inflammation at the Source: Advancing ENGI-004 to Deliver Tissue-Selective Immune Modulation in Atopic Dermatitis

More speakers at 10th Dermatology Drug Development Summit

Mudgal Kothekar
Vice President Clinical Development, Sun Pharma Advanced Research Company Ltd.
Maria Akerman
Director, Global Programs, Affibody AB
John Armstrong
Head of Healthcare Banking, Westpark Capital
Frederick Beddingfield
Chief Executive Officer & Director, Rubedo Life Sciences
Dan Brownell
Senior Director, AOBiome
Suryasarathi Dasgupta
Director - Scientific & Precision Medicine Immunology, Abbvie

See all 30 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Kenneth Crook, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].